Comparative study of porous hydroxyapatite and tricalcium phosphate as bone substitute.
This study was performed to quantitate the bone ingrowth and biodegradability of porous calcium phosphate. Two kinds of coralline hydroxyapatite (CHA), along with sintered tricalcium phosphate (TCP), were evaluated. All implants had totally interconnecting pores. These pores measured 260-600 mu for CHA-Goniopora (CHAG), 190-230 microns for CHA-Porites (CHAP), and 100-300 microns for TCP. Cylindrical implants (3 mm in diameter by 8 mm in length) were implanted into the diaphyses of rabbit tibias for 3 to 24 weeks. The quantity of regenerated bone, remaining implant, nonmineralized space, and the middle two quarters of the cortical area were measured by a computerized operator-assisted analysis for bone histomorphometry. At 3 weeks after implantation, 17.3% of CHAG, 11.3% of CHAP, and 7.0% of TCP were infiltrated by regenerated bone. At 24 weeks, 56.1% of CHAG, 52.7% of CHAP, and 44.7% of TCP were occupied by lamellar-type bone. Implant degradation was noted to be 46.4% for TCP and 27.5% for CHAP. In contrast, CHAG did not show appreciable degradation until 24 weeks.
K
K
Shimazaki
V
V
Mooney
D000818:Animals; D001672:Biocompatible Materials; D001857:Bone Matrix / Q000032:analysis; D001861:Bone Regeneration; D001842:Bone and Bones / Q000503:physiopathology / Q000601:surgery*; D002130:Calcium Phosphates; D005260:Female; D006651:Histocytochemistry; D006882:Hydroxyapatites; D019736:Prostheses and Implants; D011817:Rabbits; D013194:Staining and Labeling; D013977:Tibia / Q000601:surgery; D013997:Time Factors
D001672:Biocompatible Materials; D002130:Calcium Phosphates; D006882:Hydroxyapatites; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous